Mascola JR - Search Results

1

Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.

Julg B, Sok D, Schmidt SD, Abbink P, Newman RM, Broge T, Linde C, Nkolola J, Le K, Su D, Torabi J, Pack M, Pegu A, Allen TM, Mascola JR, Burton DR, Barouch DH. Julg B, et al. Among authors: mascola jr. J Virol. 2017 Sep 27;91(20):e01187-17. doi: 10.1128/JVI.01187-17. Print 2017 Oct 15. J Virol. 2017. PMID: 28768869 Free PMC article.

2

Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160.

VanCott TC, Mascola JR, Kaminski RW, Kalyanaraman V, Hallberg PL, Burnett PR, Ulrich JT, Rechtman DJ, Birx DL. VanCott TC, et al. Among authors: mascola jr. J Virol. 1997 Jun;71(6):4319-30. doi: 10.1128/JVI.71.6.4319-4330.1997. J Virol. 1997. PMID: 9151820 Free PMC article.

3

Potent and synergistic neutralization of human immunodeficiency virus (HIV) type 1 primary isolates by hyperimmune anti-HIV immunoglobulin combined with monoclonal antibodies 2F5 and 2G12.

Mascola JR, Louder MK, VanCott TC, Sapan CV, Lambert JS, Muenz LR, Bunow B, Birx DL, Robb ML. Mascola JR, et al. J Virol. 1997 Oct;71(10):7198-206. doi: 10.1128/JVI.71.10.7198-7206.1997. J Virol. 1997. PMID: 9311792 Free PMC article.

4

Exclusive and persistent use of the entry coreceptor CXCR4 by human immunodeficiency virus type 1 from a subject homozygous for CCR5 delta32.

Michael NL, Nelson JA, KewalRamani VN, Chang G, O'Brien SJ, Mascola JR, Volsky B, Louder M, White GC 2nd, Littman DR, Swanstrom R, O'Brien TR. Michael NL, et al. Among authors: mascola jr. J Virol. 1998 Jul;72(7):6040-7. doi: 10.1128/JVI.72.7.6040-6047.1998. J Virol. 1998. PMID: 9621067 Free PMC article.

5

Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140.

Stamatos NM, Mascola JR, Kalyanaraman VS, Louder MK, Frampton LM, Birx DL, VanCott TC. Stamatos NM, et al. Among authors: mascola jr. J Virol. 1998 Dec;72(12):9656-67. doi: 10.1128/JVI.72.12.9656-9667.1998. J Virol. 1998. PMID: 9811699 Free PMC article.

6

Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cells.

Frankel SS, Steinman RM, Michael NL, Kim SR, Bhardwaj N, Pope M, Louder MK, Ehrenberg PK, Parren PW, Burton DR, Katinger H, VanCott TC, Robb ML, Birx DL, Mascola JR. Frankel SS, et al. Among authors: mascola jr. J Virol. 1998 Dec;72(12):9788-94. doi: 10.1128/JVI.72.12.9788-9794.1998. J Virol. 1998. PMID: 9811714 Free PMC article.

7

Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies.

Mascola JR, Lewis MG, Stiegler G, Harris D, VanCott TC, Hayes D, Louder MK, Brown CR, Sapan CV, Frankel SS, Lu Y, Robb ML, Katinger H, Birx DL. Mascola JR, et al. J Virol. 1999 May;73(5):4009-18. doi: 10.1128/JVI.73.5.4009-4018.1999. J Virol. 1999. PMID: 10196297 Free PMC article.

8

The ability of an oligomeric human immunodeficiency virus type 1 (HIV-1) envelope antigen to elicit neutralizing antibodies against primary HIV-1 isolates is improved following partial deletion of the second hypervariable region.

Barnett SW, Lu S, Srivastava I, Cherpelis S, Gettie A, Blanchard J, Wang S, Mboudjeka I, Leung L, Lian Y, Fong A, Buckner C, Ly A, Hilt S, Ulmer J, Wild CT, Mascola JR, Stamatatos L. Barnett SW, et al. Among authors: mascola jr. J Virol. 2001 Jun;75(12):5526-40. doi: 10.1128/JVI.75.12.5526-5540.2001. J Virol. 2001. PMID: 11356960 Free PMC article.

9

Human immunodeficiency virus type 1 neutralization measured by flow cytometric quantitation of single-round infection of primary human T cells.

Mascola JR, Louder MK, Winter C, Prabhakara R, De Rosa SC, Douek DC, Hill BJ, Gabuzda D, Roederer M. Mascola JR, et al. J Virol. 2002 May;76(10):4810-21. doi: 10.1128/jvi.76.10.4810-4821.2002. J Virol. 2002. PMID: 11967298 Free PMC article.

10

Passive transfer studies to elucidate the role of antibody-mediated protection against HIV-1.

Mascola JR. Mascola JR. Vaccine. 2002 May 6;20(15):1922-5. doi: 10.1016/s0264-410x(02)00068-3. Vaccine. 2002. PMID: 11983246 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

619 results

Search Page